Skip to main content

Month: August 2025

Cloudastructure Inc. Schedules Second Quarter 2025 Financial Results and Business Update Conference Call

PALO ALTO, CA, Aug. 07, 2025 (GLOBE NEWSWIRE) — Cloudastructure, Inc. (Nasdaq: CSAI) (“we,” “us,” “our,” “Cloudastructure” or the “Company”) an award-winning leader in AI Surveillance and Remote Guarding, announced today that it will host a conference call on Wednesday, August 13, 2025, at 12:00 PM Eastern Time to discuss financial results for the 2025 second quarter and provide a business update. The conference call will be available via telephone by dialing toll-free +1 888-506-0062 for U.S. callers or +1 973-528-0011 for international callers and entering access code 472349. A webcast of the call may be accessed at https://www.webcaster4.com/Webcast/Page/3134/52818 or on the investor relations section of the company’s website, https://investor.cloudastructure.com/. A webcast replay will be available on the investor relations...

Continue reading

Encryption-In-Use Technology Would Have Neutralized the Allianz Life Insurance Breach

HACKENSACK, N.J., Aug. 07, 2025 (GLOBE NEWSWIRE) — Paperclip Inc., a leader in advanced data security and content supply-chain solutions, today confirmed that encryption-in-use technology could have prevented the exposure of sensitive customer data in the recent Allianz Life Insurance data breach, which impacted over 1.4 million U.S. customers. Allianz Breach Context: What HappenedOn July 16, 2025, Allianz Life Insurance reported a massive data compromise following a social engineering attack that targeted a third-party cloud-based customer relationship management (CRM) system. Attackers were able to extract personally identifiable information (PII), including names, addresses, dates of birth, Social Security numbers, and policy identifiers, putting millions at risk for identity theft and fraud. Although Allianz Life Insurance...

Continue reading

Qualstar Corporation Reports Second Quarter 2025 Results

Gross Margin Expands to 34% With Positive Net Income and Solid Cash Position; Company Advances Strategic Growth Initiatives in Data Storage and Power Solutions IRVINE, Calif., Aug. 07, 2025 (GLOBE NEWSWIRE) — Qualstar Corporation (OTC: QBAK), a trusted provider of scalable data storage and high-efficiency power solutions, today announced financial results for the second quarter ended June 30, 2025. Qualstar’s second quarter results reflect meaningful gross margin expansion, continued profitability, and a solid cash position. While revenue declined year-over-year due to the previously disclosed loss of a large power-supply customer, the Company remains focused on executing its strategic initiatives and is well-positioned to capitalize on demand for secure, long-term data storage solutions. Second Quarter 2025 Key HighlightsGross...

Continue reading

GoldHaven Announces Refiling of 43-101 Technical Report on Copeçal Project

VANCOUVER, British Columbia, Aug. 07, 2025 (GLOBE NEWSWIRE) — GoldHaven Resources Corp. (“GoldHaven” or the “Company“) (CSE: GOH) (OTCQB: GHVNF) (FSE: 4QS) is pleased to announce, further to its news release dated May 16, 2025, the refiling of an independent technical report for its Copeçal Project prepared in accordance with National Instrument 43-101 – Standards of Disclosure for Mineral Projects. The technical report, titled “Technical Report on the Geology, Mineralization and Exploration of the Copeçal Gold Project, Mato Grosso State, Northwestern Brazil” and with an effective date of May 29, 2025 can be found on the Company’s SEDAR+ profile at www.sedarplus.ca and on the Company’s website here. Key Highlights: Strategically Located in Tier-One Mining Jurisdiction The Copeçal Gold Project spans 3,681.76...

Continue reading

Tevogen Receives $1 Million to Accelerate AI-Driven Drug Discovery; Remains Well Capitalized to Execute Growth Strategy

Funds will support advancement of Tevogen.AI, the Company’s artificial intelligence–driven drug discovery initiative. The $1 million is part of up to $10 million in previously announced non-dilutive grant funding from KRHP LLC. The Company remains well-capitalized, enabling it to fully execute its growth strategy.WARREN, N.J., Aug. 07, 2025 (GLOBE NEWSWIRE) — Tevogen Bio Holdings Inc. (“Tevogen” or the “Company) (Nasdaq: TVGN), today announced it has received the previously reported $1 million in funding to advance Tevogen.AI, its artificial intelligence–powered drug discovery and development program. The funding is provided through an agreement with KRHP LLC, under which Tevogen received $2 million in January 2025 and may receive up to an additional $8 million, for an aggregate of $10 million in nondilutive funding. KRHP...

Continue reading

Arqit selected to join Vodafone’s innovation centre Tomorrow Street: Scaleup X programme to explore new business opportunities

LONDON, Aug. 07, 2025 (GLOBE NEWSWIRE) — Arqit Quantum Inc. (Nasdaq: ARQQ, ARQQW), a global leader in quantum-safe encryption, today announced that it has joined the 2025 cohort of Tomorrow Street’s Scaleup X programme. The collaboration provides Arqit with access to Tomorrow Street’s global network and ecosystem, creating opportunities to scale its technology across Vodafone’s ecosystem. Tomorrow Street, Vodafone’s innovation centre based in Luxembourg, connects high-growth technology companies with partners and customers worldwide. Through Tomorrow Street’s Scaleup X programme, Arqit will explore opportunities to apply its quantum-safe Symmetric Key Agreement (SKA-Platform™) to support businesses in securing critical communications and data against evolving cyber threats, including those posed by quantum computing. Participation...

Continue reading

Live Ventures Reports Fiscal Third Quarter 2025 Financial Results

LAS VEGAS, Aug. 07, 2025 (GLOBE NEWSWIRE) — Live Ventures Incorporated (Nasdaq: LIVE) (“Live Ventures” or the “Company”), a diversified holding company, today announced financial results for its fiscal third quarter 2025 ended June 30, 2025.  Fiscal Third Quarter 2025 Key Highlights:Revenue was $112.5 million, compared to $123.9 million in the prior-year period Gross margin expanded to 34.0%, compared to 29.9% in the prior-year period, representing a 410 basis point improvement Operating income increased $6.9 million, or 607.6%, to $8.0 million, compared to $1.1 million in the prior-year period Net income increased $8.2 million to $5.4 million, and diluted earnings per share (“EPS”) were $1.24, compared to the prior-year period net loss of $2.9 million and diluted loss per share of $0.91. Net income for the third quarter of...

Continue reading

Runway Growth Finance Corp. Announces Third Quarter 2025 Total Distribution of $0.36 per Share

Distribution comprised of a $0.33 per share regular dividend and a $0.03 per share supplemental dividend MENLO PARK, Calif., Aug. 07, 2025 (GLOBE NEWSWIRE) — Runway Growth Finance Corp. (Nasdaq: RWAY) (“Runway Growth” or the “Company”), a leading provider of flexible capital solutions to late- and growth-stage companies seeking an alternative to raising equity, today announced that its Board of Directors has declared total distributions for the third quarter of $0.36 per share, comprised of a regular cash dividend of $0.33 per share and a supplemental dividend of $0.03 per share. The following shows the key dates of the third quarter 2025 dividend, including the supplemental dividend: Declaration Date: August 6, 2025Record Date: August 18, 2025Payment Date: September 2, 2025 Runway Growth generally intends to distribute, out of...

Continue reading

Bill Corl of Omega Laboratories Joins Cannabix Technologies Board of Directors

VANCOUVER, British Columbia, Aug. 07, 2025 (GLOBE NEWSWIRE) — Cannabix Technologies Inc. (CSE: BLO) (OTC PINK: BLOZF) (Frankfurt: 8CT) (the “Company or Cannabix”) is pleased to announce William (Bill) R. Corl has joined the board of directors of the Company. Mr. Corl is the Chief Executive Officer for Omega Laboratories, Inc., (“Omega”) one of the leading advanced specimen drug testing laboratories in the world. Omega and Cannabix have been working together since May 2024 under a strategic partnership and development agreement to advance commercialization of the Company’s Marijuana Breath Test (MBT) technology. Mr. Corl has spent the last twenty-six years creating and managing technology solutions in the diagnostic testing, media and radiology industries. Mr. Corl has spent the last twenty plus years helping advance the drug screening...

Continue reading

SS Innovations Reports Second Quarter 2025 Financial Results

Record Quarterly Revenue of $10.0 Million Driven by Higher SSi Mantra 3 Unit Sales Gross Profit More than Tripled, Driven by Gross Margin Expansion and Revenue Growth    FORT LAUDERDALE, Fla., Aug. 07, 2025 (GLOBE NEWSWIRE) — SS Innovations International, Inc. (the “Company” or “SS Innovations”) (Nasdaq: SSII), a developer of innovative surgical robotic technologies dedicated to making robotic surgery affordable and accessible to a global population, today announced unaudited financial results for the three and six months ended June 30, 2025.   The Company also filed its Quarterly Report on Form 10-Q for the quarter ended June 30, 2025, with the Securities and Exchange Commission on August 6, 2025. Second Quarter 2025 OverviewRevenue increased 121.8% to $10.0 million from $4.5 million in the second quarter of 2024. Gross margin...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.